Oramed Pharmaceuticals Inc.ORMPNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.05
Net Income/Share$1.05
Operating CF/Share$-0.26
Free CF/Share$-0.26
Cash/Share$3.23
Book Value/Share$4.85
Tangible Book/Share$4.85
Equity/Share$4.87
Interest Debt/Share$-0.29
CapEx/Share$0.00
Dividend/Share$0.25
Valuation
Market Cap$134.29M
Enterprise Value$82.97M
P/E Ratio3.21P/S Ratio67.14P/OCF Ratio-12.78
P/FCF Ratio-12.18
P/B Ratio0.69P/TB Ratio0.69
EV/Sales41.48EV/EBITDA1.42
Graham Valuation
Graham Number$10.73
Graham Net-Net$2.79
Profitability
Earnings Yield31.16%FCF Yield-8.21%ROE27.20%ROIC-4.76%Return on Tangible Assets19.89%Dividend
Dividend Yield7.42%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.17%
CapEx/Revenue0.92%
CapEx/Depreciation0.15
SBC/Revenue109.45%
SG&A/Revenue358.50%
R&D/Revenue292.70%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00Debt/Market Cap0.01
Net Debt/EBITDA-0.88
Current Ratio22.24Interest Coverage1.01xIncome Quality-0.25Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding98 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover3.71x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$202.33M
Working Capital$130.00M
Invested Capital$131.43M
Intangibles/Assets0.00%